Clinical Trial Update: A Study of Letrozole in the Treatment of Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole for recurrent and metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Recurrent and Metastatic Endometrial Cancer | Phase 2 | Status: COMPLETED